GPRC6A and prostate cancer: We also used clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 nuclease (Cas9) (CRISPR/Cas9) [34] to disrupt the GPRC6A gene in the human prostate cancer cell line (PC-3).